ASTS three-lens brief
Evidence-based stock research on ASTS. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -4.02% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved -4.02% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Outperforming SPY by 9.1pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $79.61 — 33% above current (12 analysts).
ASTS closed at $59.91 (-4.02%) as of 2026-09-11. Market cap: $23.32B. Price is below the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 9.1pp over 30 days.; analyst mean target $79.61 — 33% above current (12 analysts).. Concerns: moved -4.02% yesterday.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $31.52M, net income -$230.91M, free cash flow -$1.80B.
Why three lenses on ASTS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ASTSacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ASTS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ASTS brief"></iframe>